Pfizer — The drug maker earned an adjusted 53 cents per share for the fourth quarter, 1 cent above estimates, with revenue also beating forecasts. Pfizer was helped by demand for its pneumonia vaccine and its recent acquisition of Hospira. However, Pfizer did forecast full-year 2016 earnings that are slightly below Street forecasts.
Michael Kors — The luxury goods maker beat estimates by 13 cents with adjusted quarterly profit of $1.59 per share, and revenue also came in above forecasts. Kors was helped by particular strength in accessories and footwear.